Health ❯Healthcare ❯Vaccines ❯COVID-19

Moderna

FDA Approves Moderna’s mNEXSPIKE for High-Risk Populations

Rollout is planned for the 2025-26 respiratory virus season under a new policy limiting COVID-19 boosters to high-risk groups.

Trump Withdraws Jared Isaacman’s NASA Nomination Days Before Senate Vote

Health Canada Approves Moderna's Updated COVID-19 Vaccine